Some diabetes therapies work by ramping up the body’s secretion of insulin to counteract high blood sugar levels. | Preserving insulin-producing pancreatic beta cells—rather than exhausting them—might be a better strategy in the treatment of diabetes. Following that thinking, scientists at the Karolinska Institute found a cancer drug by Seagen holds promise for the metabolic disease.
Comments are closed.